DrugsControl Media Services

News Detail

Glenmark Pharmaceuticals and Ichnos Sciences establish alliance for cancer drug discovery (31-01-2024)

Mumbai, 31 Jan 2024: Glenmark Pharmaceuticals Ltd. and its subsidiary, Ichnos Sciences Inc. on Tuesday said that they have launched a collaborative effort named Ichnos Glenmark Innovation (IGI) to expedite the development of new cancer treatments.  


View Details

Source : Business Today
Glenmark Pharmaceuticals Ltd Ichnos Sciences Inc Ichnos Glenmark Innovation cancer treatments collaboration small molecule research novel biologics orphan drug designation U.S. FDA autoimmune disease assets hematological malignancies solid tumors oncology molecules clinical trials multiple myeloma acute myeloid leukemia drug discovery ISB 1442 ISB 2001 GRC 54276 ISB 880 ISB 830 Telazorlimab advanced therapies shareholder value drug development New York City Lausanne Switzerland Mumbai India biotech companies academic entities

Related News